# FDA’s top gene therapy regulator is leaving his role

> **Open Intelligence Dossier** · First detected: 2026-06-30 19:07 UTC · Category: Business

## Executive Summary
11 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"FDA’s top gene therapy regulator is leaving his role" is generating significant coverage in the Business category, with 12 articles from 11 distinct sources tracked by PULSE so far.


Outlets currently covering the story include Yahoo, TradingView, PharmTech.com and GlobeNewswire. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Yahoo | US FDA rejects approval of Unicycive’s kidney disease therapy | [Source Link](https://news.google.com/rss/articles/CBMilwFBVV95cUxQU1FHZVZRcGV2MTNYR08xR3R3N25LOTEzM0ZfT0Z2UXdzWkJOUmxYc0RfMlVVQUZkYU1aSXZwQ2hDZFNHZ1VNTk9TWkhLcnVITDVzWE85SWZvNHpJM2hjMHpWcnUzTUxmanlqMHZsM3pqSTl2d1lqM0ZTX3d0YXE4dGU2cjc1Z0V6X0NGSnRtZ1dMX2o3aFJV?oc=5) |
| TradingView | UNCY Stock Clocks Worst Day In A Year — Analysts Keep Buy Ratings Despite ‘5-12 Month Delay’ In Drug Approval | [Source Link](https://news.google.com/rss/articles/CBMi-gFBVV95cUxNNEhLQnlkSEl4SGswWkhyTm5FTHRPMlhHTHVheGU1RXhkeVhpMmVUSFBNcTdJVXB6Z0hjQjEtOVlFZmdCTV80dHR3ZjNOZkFuLXZ3LUhCbTRnbzQxSU8tQVdxdUpUcm02dXg2Z3BzT2RsUXFKU0hBRGd0bFplaUkwYU5YZHVCQzV3OUtOT05kNEtTUXlYelU5QTc2M0d0cWE2dV8wRFhvdjYxUDlONmVmaFZhMC1lUnNXSThPWFNzZGhZVmFwRmhpV09yeDRsbHlkSWFTdGZQZXZTRVp1ZkJ3YTBYYWNFRGswR2hwS3BMS1JKalBHc2VzZTRn?oc=5) |
| PharmTech.com | Manufacturing Deficiencies Behind FDA's Oxylanthanum Carbonate Rejection | [Source Link](https://news.google.com/rss/articles/CBMipAFBVV95cUxOekN1SGZPNjIwVTIzUXZVdnVMclcybmRFc25iWnV2MlJDWUpXZmFpellOU2k3TnRXZ0tVT3FPX3JVV0hYNDhDVk9ta2tybDJfRVdGUHM5dUpLaEJaNllEcUV2UTN5QS1MbTRQaHM0NTVCRlRnUFRGSU5acERsWTZhWVZJT1hRNWZoSmdGOUFoSEtiRzR6Qk10VGdKZ2Q4aHNwRU4yYw?oc=5) |
| GlobeNewswire | Unicycive Therapeutics Receives Complete Response Letter | [Source Link](https://news.google.com/rss/articles/CBMitgJBVV95cUxPcnFtSV9TdjN1Vk03Ny0xeHREdzZEbW9kaGZSX3Rrck5MQU1WOW5Dc2E5X21KOVpmNWYwakNvRzIza0w5eW5RRmxaN1V6aVpkaEt0blhCX2tUOXE1YmN5S09fRDFBM0hUMEt4V0tBeU4yVjU0MTdBTENqU0RLempUb0NyV0xwOWR5RTliaFJIR0Yzb2phN0REZEZVcmQ5dTB0OTNXMmlWU3dyS3liMEZuZEFVVTlhTjAtTjd6OWdYam9lbUNMUWJMWl9lVWNJMVVzeXRNd2V6V2l2SXI2X3owNDI3cTdzTzVnSXhLRjIxWHVrT3V5emtRWGV2V0tMdkFvcG5HWEtvTTJ2ZDlCVHU5S2tMY2ltR0FNYmxGZVU1T3hnQzk0Yy13dWtEM3dJXzQyUHloZlln?oc=5) |
| Yahoo Finance | Unicycive shares plunge after FDA issues Complete Response Letter for kidney disease drug (UNCY) | [Source Link](https://news.google.com/rss/articles/CBMimwFBVV95cUxNSEtlRDA2bmZmUnJubXJUMEJkeDJUUDlzWGg3ZEdjTmVva0hMcW5LcGhZSHZieF9wdTIwcHR5N1NheTFKYnpiZ2NTOFQ4SmNlZ2tfaVpWY1J6ZEVmODRNck56amRUSmFnZGhwLXgyZTRXWU1jQklvVnU0TlBieEJfcXF1Zmw1VW54V2ZfU2I4WTV0VHgwRlR2RHJwRQ?oc=5) |
| Reuters | US FDA declines to approve Unicycive's kidney disease drug | [Source Link](https://news.google.com/rss/articles/CBMirwFBVV95cUxOVTVvNk9BVXdIM3RhNXdxaXM5TGxOR0R4VFYwZzhmeWVqQVpjdkRXSGpsQ2NXUEIzNFRiTzBFbTdSanRTSHVYNGdFODA2a0Q1ajFLVGlhZ1lYcG1tXzlwaXZ4WDBwSHJkNlJxN0ZsQVNlb0NQa0Q1T29kcE1wVVlWMENvRHFyR2FBaU1oT3QwYnRUYWhzcHFqYV9pZk1FQWlxVUx5Nlc0NTh1ZzNhTnJR?oc=5) |
| BioPharma Dive | Top FDA gene and cell therapy regulator to step down | [Source Link](https://news.google.com/rss/articles/CBMikgFBVV95cUxPQXdJMHhXWVIxVk1WVnVXb3NmZFhOSndNQmIyTjRMOHhHcGVOOHBVc3pQMXIycGNwSVJSZUZXNDlqSy1XaGxBVzRadUtnOWtoalBodUZrQkQ1clBXZENkUHUza2tIWGttcy11NnhXWm1jNVlIUzFqMTd3S1NWaU5JOXpkZlBSRkU0REQ1SWR0aDNJUQ?oc=5) |
| BioSpace | FDA’s cell and gene therapy head steps down after 1 year | [Source Link](https://news.google.com/rss/articles/CBMijAFBVV95cUxPV1FvY3ZGRFJIZWpsRkEtTGVoOGhWR2x2ZDE0TjZWRFNBeWVrRWE5cmp0Q21RdTJDX1ZXdlN2WWVGTWRZZG8tMmxwMWFHdWlfdjdsdEluNGwySXB0bEN3Q0Z4a0xiZXhJUFRRVkl1QjlrWUliUTdzQmxlemNoREdrMjlwOXhkYllRZFlsbA?oc=5) |
| Yahoo | Top FDA gene and cell therapy regulator to step down | [Source Link](https://news.google.com/rss/articles/CBMijAFBVV95cUxPaWd5eW1mY0wyZm9QbTRiYzlGc01YRng2cUtiRWtaajlpSDJTcVV2Y3RZX0VSd3pVbWxpancyZ3R6cmVnUHJ2clJFTXZhSDh6QUtIZTBhUVlpb2ZheFNvd2t1T1NpUlROR0NLXzhTcUtjTFQtOGt4d1dqQm5YT1k1M1RGcDlJTFlTTlFYcg?oc=5) |
| Endpoints News | FDA’s acting director of cell and gene therapies to leave position | [Source Link](https://news.google.com/rss/articles/CBMikwFBVV95cUxPWWZWTDZxMWVZQTdoSzZqaS1pd3hMOTF6WjVmcE5xVkJFN2tHSHBvVkRNWlNIN2JtS2hldjg0SnZudWowVGRTVFhaQ1dVMHpIeG1pT2V1emNVbWlGVl9QSmQwMFNIRUY3YUFDczhpcW9pcU5iTDZuVThxbWFnZThBcnhwNW8xaVVhaEV5dkpkaDBuNkk?oc=5) |
| Fierce Biotech | FDA gene therapy regulator steps down from leadership role | [Source Link](https://news.google.com/rss/articles/CBMipgFBVV95cUxQWkhmRjF6UmNoOVRTazNhRU9NLU1ZaGJYX2tkS0FIaDFsU2otUVBkZDNJOVZKdFVCSk5NZXh6LTFlTzlLelpoQ29PUGRUQVYzLVlOSFd6bTZfZWtwUV8zMm1pTGRHc3BOU2YyWmM4bEUxemtueS1IYkdWUFlsd05SR1N3TTBUUERVYjdWNjI2YllmNWtnbWVWVlM5SDFvNG9IQmt2dndn?oc=5) |
| statnews.com | FDA’s top gene therapy regulator is leaving his role | [Source Link](https://news.google.com/rss/articles/CBMikwFBVV95cUxNLUxyTFhnSnJrR1VkVnhacHFTRkZQdi16aWdCdFR2ai1jS0RzakFKeW9tR0hEMk5RZmNDTFRRMmMtZGlqaWNFazdCc3c4Z3NpYUNjeHBHb0N0aFA1Y0VMRjRIc21OaTR4YzZVdVFUeVhsMHl3OHV0SEdXVzMtRjg3MWtSajhUTUJYdkdFdkhXX1ZnaFE?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-06-30/fda-s-top-gene-therapy-regulator-is-leaving-his-role*